(Q37947907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sara Gandini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Matteo Puntoni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alessandra Gennari

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

Andrea DeCensi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

Bernardo Bonanni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

20 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

S36-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

Free radicals and antioxidants - quo vadis?

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Free radical tissue damage: protective role of antioxidant nutrients.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Antioxidants and disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

1 reference

7 January 2021

Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

For my wellness, not just my illness: North Americans' use of dietary supplements.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Antioxidant supplements for preventing gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Role of reactive oxygen species (ROS) in apoptosis induction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Toxicity and roles of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

The toxicity of antioxidants and their metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

25-hydroxyvitamin D levels and the risk of mortality in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Calcium plus vitamin D supplementation and the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Calcium plus vitamin D supplementation and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Calcium plus Vitamin D and the Risk of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Vitamin D deficiency: a worldwide problem with health consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

1 reference

7 January 2021

Vitamin D and prevention of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Distribution of fenretinide in the mammary gland of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

How retinoids regulate breast cancer cell proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Retinoids and apoptosis: implications for cancer chemoprevention and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Mechanism of fenretinide (4-HPR)-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Role of antioxidants and intracellular free radicals in retinamide-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Mechanisms of fenretinide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

4-HPR modulates gene expression in ovarian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

Synthetic retinoid fenretinide in breast cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970292-2

7 January 2021

10.1016/S0960-9776(11)70292-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015291%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference